You are here:

NICE
NICE Guidance
Conditions and diseases
Digestive tract conditions
Inflammatory bowel disease

Infliximab for acute exacerbations of ulcerative colitis

Technology appraisal guidance
Reference number: TA163
Published: 17 December 2008

Guidance
Tools and resources
Information for the public
Evidence
History

Appendix A: provisional matrix of stakeholders

Appendix A: provisional matrix of stakeholders

Appendix A: provisional matrix of stakeholders
06 April 2011
(83.5 Kb 24 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 06 April 2011